{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,12,18]],"date-time":"2024-12-18T05:31:24Z","timestamp":1734499884371,"version":"3.30.2"},"reference-count":7,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the Academy of Consultation-Liaison Psychiatry"],"published-print":{"date-parts":[[2024,11]]},"DOI":"10.1016\/j.jaclp.2024.07.007","type":"journal-article","created":{"date-parts":[[2024,7,26]],"date-time":"2024-07-26T23:46:16Z","timestamp":1722037576000},"page":"584-585","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Pimavanserin for Delirium Management in the Setting of Parkinson's Disease: A Case Report"],"prefix":"10.1016","volume":"65","author":[{"given":"Matthew","family":"Gunther","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shixie","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1723-0457","authenticated-orcid":false,"given":"Jose R.","family":"Maldonado","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jaclp.2024.07.007_bib1","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1007\/s00702-019-01980-7","article-title":"Management of delirium in Parkinson\u2019s disease","volume":"126","author":"Ebersbach","year":"2019","journal-title":"J\u00a0Neural Transm Vienna Austria"},{"key":"10.1016\/j.jaclp.2024.07.007_bib2","article-title":"A\u00a0Retrospective Analysis of guanfacine for the pharmacological management of delirium","volume":"15","author":"Jiang","year":"2023","journal-title":"Cureus"},{"key":"10.1016\/j.jaclp.2024.07.007_bib3","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.psym.2020.10.003","article-title":"Guanfacine for Hyperactive delirium: a case Series","volume":"62","author":"Jiang","year":"2021","journal-title":"J\u00a0Acad Consult-Liaison Psychiatry"},{"key":"10.1016\/j.jaclp.2024.07.007_bib4","doi-asserted-by":"crossref","first-page":"365","DOI":"10.2217\/nmt-2017-0028","article-title":"Parkinson\u2019s disease psychosis: presentation, diagnosis and management","volume":"7","author":"Schneider","year":"2017","journal-title":"Neurodegener Dis Manag"},{"key":"10.1016\/j.jaclp.2024.07.007_bib5","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1017\/S1092852916000407","article-title":"Mechanism of action of pimavanserin in Parkinson\u2019s disease psychosis: targeting serotonin 5HT2A and 5HT2C receptors","volume":"21","author":"Stahl","year":"2016","journal-title":"CNS Spectr"},{"key":"10.1016\/j.jaclp.2024.07.007_bib6","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1016\/j.ccc.2017.03.013","article-title":"Acute Brain failure","volume":"33","author":"Maldonado","year":"2017","journal-title":"Crit Care Clin"},{"year":"2020","series-title":"NUPLAZID (pimavanserin) [package insert]","key":"10.1016\/j.jaclp.2024.07.007_bib7"}],"container-title":["Journal of the Academy of Consultation-Liaison Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2667296024000752?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2667296024000752?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,12,17]],"date-time":"2024-12-17T12:36:07Z","timestamp":1734438967000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2667296024000752"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11]]},"references-count":7,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2024,11]]}},"alternative-id":["S2667296024000752"],"URL":"https:\/\/doi.org\/10.1016\/j.jaclp.2024.07.007","relation":{},"ISSN":["2667-2960"],"issn-type":[{"type":"print","value":"2667-2960"}],"subject":[],"published":{"date-parts":[[2024,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Pimavanserin for Delirium Management in the Setting of Parkinson's Disease: A Case Report","name":"articletitle","label":"Article Title"},{"value":"Journal of the Academy of Consultation-Liaison Psychiatry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaclp.2024.07.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Academy of Consultation-Liaison Psychiatry. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}